Group 1 - NuraNavX, a brain science AI company, recently completed a multi-million yuan angel round financing led by K2 Venture Partners, with funds aimed at market promotion and further R&D of AI brain connectomics products [1] - The company's AI-based individualized brain network mapping, which can be understood as a "GPS for the brain," reveals how different brain regions connect, crucial for understanding complex brain diseases [1] - NuraNavX divides each patient's brain into 379 unique regions based on MRI data and has identified over 20 important brain functional networks, enabling personalized brain network maps for surgical protection and targeted treatment of central nervous system diseases like depression and anxiety [1] Group 2 - The company has established self-operated neuroregulation clinics in Shenzhen and Shanghai, providing treatments for various conditions including depression, anxiety, insomnia, and schizophrenia [2] - In addition to medical-grade products and services, NuraNavX's AI brain connectomics software supports researchers in brain science and has developed consumer-level brain health assessment reports to identify potential risks early [2]

36氪获悉，脑科学AI公司曦嘉医疗（NuraNavX）近日完成数千万元天使轮融资，由险峰淇云（K2 Venture Partners）投资。本轮融资主要用于进行AI脑连接 组学产品的市场推广和进一步研发等。公司将于今年年中启动新一轮融资。 脑连接组学，通过分析大脑神经元之间的连接和组网方式来研究大脑。曦嘉医疗基于脑连接组学的AI个体化脑网络图谱，可简单理解为绘制大脑GPS，与传 统的脑部成像技术不同，它揭示大脑不同区域如何相互连接形成脑网络，进而理解大脑不同区域的功能和运作机制，这对于理解复杂脑部疾病的发生机制至 关重要，并据此在国内临床治疗了超过1000例患者。 曦嘉医疗的靶点定位逻辑 "一部分疾病，如抑郁症、自闭症、严重失眠等，并非是脑区出现器质性病变，而是因为脑功能区的连接出现异常。"曦嘉医疗CFO原泉介绍道。 基于MRI数据，曦嘉医疗将每个患者大脑划分为379个独特的脑区，并通过连接各个分区的神经纤维束研究和归纳了20多个重要脑功能网络。"通过独创的 SCA（结构连接图谱），我们能够为每个患者生成个性化的脑网络图谱，进而用于神经外科手术中的脑功能区保护，以及抑郁症、焦虑症等中枢神经疾病的 治疗靶区定位 ...